Skip to main content
Clinical Trials/NCT04306211
NCT04306211
Terminated
Not Applicable

Comparison of Oxygenation Between Nasal Positive Airway Pressure (PAP) Versus Standard Care During Propofol-based Sedation for Endoscopic Ultrasound in an Ambulatory Surgical Setting: a Prospective Randomized Control Trial

Indiana University2 sites in 1 country11 target enrollmentDecember 14, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endoscopic Ultrasound
Sponsor
Indiana University
Enrollment
11
Locations
2
Primary Endpoint
Benefit of Nasal PAP Versus Nasal Administration of Oxygen
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

Randomized controlled single site study involves oxygenation, continuous positive airway pressure, and ventilation of subject via nasal mask and oxygenationvia closed facemask. The intervention of the study are delivery form of supplemental oxygen, bag-mask ventilation, and continuous nasal CPAP intraoperatively and in the post anesthesia care period.

Detailed Description

124 patients with BMI\> or equal to 35kg.m2 or documented Obstructive Sleep Apnea scheduled for an EUS with Propofol sedation will be randomized to CPAP vs nasal mask for oxygenation during their procedure. Patients will be monitored every 2 minutes during the procedure and in the recovery area until discharge. If patients have difficulty or refuse to wear the mask, 2 or more simultaneous or non-synchronous adverse events, change in heart rhythm or ST changes on EKG they will immediately changed to the other group. The ansethesiologist, gastroenterologist \& patient will complete post-procedure questionnaires regarding their opinion of the oxygen delivery system.

Registry
clinicaltrials.gov
Start Date
December 14, 2020
End Date
March 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

John DeWitt

Associate Professor of Medicine

Indiana University

Eligibility Criteria

Inclusion Criteria

  • Age 18 years of age or older
  • Patients undergoing upper endoscopic ultrasound
  • American Society of Anesthesiology (ASA) Physical Status I-III
  • BMI ≥35 kg/m2 or documented Obstructive Sleep Apnea
  • Has provided written informed consent

Exclusion Criteria

  • Inpatient status
  • Active Congestive Heart Failure Exacerbation
  • Untreated ischemic heart disease
  • Acute exacerbation of respiratory disorders, including COPD and asthma
  • Emergent procedures
  • Previous enrollment in this study
  • Inability to provide informed consent
  • Additional medical testing planned for the same day
  • History of allergic reaction to Propofol
  • Tracheostomy

Outcomes

Primary Outcomes

Benefit of Nasal PAP Versus Nasal Administration of Oxygen

Time Frame: 60 minutes.

Compare the incidence, duration, and severity of oxygen desaturation

Secondary Outcomes

  • Procedural Interruptions(60 minutes)
  • Total Amount of Propofol for Adequate Sedation(60 minutes.)
  • Modified Observer's Assessment and Alertness/Sedation Scale (MOAAS)(120 minutes)

Study Sites (2)

Loading locations...

Similar Trials